Transient Tcf3 Gene Repression by TALE-Transcription Factor Targeting.

Area of Science:

• Stem Cell Biology
• Gene Regulation
• Cell Therapy

Background:

• Hematopoietic stem and progenitor cell (HSC) transplantation is a vital therapy for hematopoietic diseases.
• HSCs are limited in number and prone to senescence, necessitating methods for in vitro expansion.
• Maintaining HSC multipotentiality and self-renewal during expansion is crucial for successful transplantation.

Purpose of the Study:

• To develop a novel method for expanding hematopoietic stem cells (HSCs) in vitro.
• To maintain HSC multipotentiality and self-renewal capacity during expansion.
• To target and transiently repress the TCF3 gene using a specifically engineered vector.

Main Methods:

• Construction of an episomal expression vector encoding a transcription activator-like effector (TALE) fused to a Krüppel-associated box (KRAB) repressor.
• Utilizing the TALE-KRAB vector to specifically target and repress the TCF3 gene.
• Validation of TCF3 repression in HEK293, COS-7 cell lines, and a human B lymphoma cell line.

Main Results:

• The TALE-KRAB vector demonstrated efficient repression of an exogenous reporter gene in cell lines.
• The vector successfully repressed endogenous TCF3 expression in a human B lymphoma cell line.
• These results indicate the vector's potential for maintaining HSC multipotentiality during expansion.

Conclusions:

• A novel TALE-KRAB vector effectively represses TCF3 gene expression.
• This TCF3 repression strategy shows promise for in vitro expansion of HSCs.
• The developed vector could enhance cell therapy by providing sufficient, multipotent HSCs for transplantation.